eTable 5. Sensitivity analysis of regression*1.
Level | No symptoms vs. any duration | Post-COVID-19 vs. no symptoms or duration <12 weeks | |||||
OR | 95% CI | p-value | OR | 95% CI | p-value | ||
Age | Continuous | 0.988 | [0.975; 1.001] | 0.070 | 1.006 | [0.999; 1.014] | 0.105 |
Sex | Female | 1.556 | [1.028; 2.355] | 0.037 | 1.921 | [1.529; 2.414] | < 0.001 |
Male | Reference | Reference | |||||
Educational level*2 | Metric | 1.356 | [1.182; 1.556] | < 0.001 | 1.112 | [1.019; 1.214] | < 0.017 |
Nursing home resident | Yes | 0.145 | [0.068; 0.309] | < 0.001 | 0.156 | [0.072; 0.334] | < 0.001 |
No | Reference | Reference | |||||
SCQ-D | Continuous | 1.012 | [0.955; 1.073] | 0.68 | 1.110 | [1.069; 1.153] | < 0.001 |
Hospitalized during acute COVID-19 | Yes | 3.432 | [1.587; 7.422] | 0.002 | 1.839 | [1.407; 2.404] | < 0.001 |
No | Reference | Reference | |||||
Need for analgesics during acute COVID-19 | Yes | n.d.*3 | n.d.*3 | n.d.*3 | 1.528 | [1.059; 2.205] | 0.024 |
No | n.d.*3 | Reference |
*1 As sensitivity analysis, binary logistic regression models were calculated by combining two out of three categories that were also used in the multiple ordinal ?logistic regression (1, no symptoms; 2, symptom duration < 12 weeks; 3, symptom duration ≥ 12 weeks) (n = 1459; imputed data set with 500 imputations)
*2 Only one parameter was estimated in a linear coding of educational status with six different levels.
*3 The predictor “need for analgesics during acute COVID-19” was excluded from the analysis of no symptoms vs. any duration, because all patients who took analgesics also had symptoms (of any duration).
CI, Confidence interval; n.d., no data; OR, odds ratio; SCQ-D, Self-Administered Comorbidity Questionnaire, German version